- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/04 - Mycobacterium, e.g. Mycobacterium tuberculosis
Patent holdings for IPC class A61K 39/04
Total number of patents in this class: 1086
10-year publication summary
|
78
|
74
|
68
|
63
|
67
|
59
|
47
|
65
|
52
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1595 |
30 |
| Access to Advanced Health Institute | 76 |
22 |
| International AIDS Vaccine Initiative, Inc. | 62 |
20 |
| Longhorn Vaccines and Diagnostics, LLC | 92 |
19 |
| Statens Serum Institut | 85 |
18 |
| Vakzine Projekt Management GmbH | 29 |
18 |
| Wisconsin Alumni Research Foundation | 3915 |
17 |
| Altor BioScience, LLC | 79 |
17 |
| The Regents of the University of California | 20590 |
15 |
| Rutgers, The State University of New Jersey | 1959 |
15 |
| The Johns Hopkins University | 5844 |
14 |
| Immodulon Therapeutics Limited | 42 |
14 |
| Institut Pasteur | 787 |
13 |
| The General Hospital Corporation | 4840 |
12 |
| Infectious Disease Research Institute | 44 |
12 |
| Albert Einstein College of Medicine, Inc. | 593 |
11 |
| Archivel Farma, S.L. | 13 |
11 |
| University of Georgia Research Foundation, Inc. | 1067 |
11 |
| The UAB Research Foundation | 661 |
10 |
| BioNTech SE | 784 |
10 |
| Other owners | 777 |